Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $7B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Anika Therapeutics USD 213M 28M Mar/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025